Table 1. Study characteristics.
First author | Study location | Yeara | Number of cases/controls | Source of control selection | % −308A allele frequencyb | % −238A allele frequencyc | % −857T allele frequencyd | P, HWE −308e | P, HWE −238f | P, HWE −857g | |
---|---|---|---|---|---|---|---|---|---|---|---|
1 | Jang | Korea (E) | 2001 | 52/92 | Healthy volunteers | 3.8 | 7.1 | — | 0.70 | 0.39 | — |
2 | Wu | Taiwan (E) | 2002 | 150/220 | Healthy volunteers | 12.0 | 1.8 | — | <0.01 | <0.01 | — |
3 | El-Omar | USA (W) | 2003 | 314/210 | Population based | 15.2 | — | — | 0.55 | — | — |
4 | Machado | Portugal (W) | 2003 | 287/304 | Healthy volunteers | 12.7 | — | — | 0.65 | — | — |
5 | Fei | China (E) | 2004 | 56/164 | Healthy volunteers | 6.7 | — | — | 0.12 | — | — |
6 | Glas | Germany (W) | 2004 | 88/145 | Healthy volunteers | 15.2 | 3.8 | — | 0.67 | 0.63 | — |
7 | Lee SG | Korea (E) | 2004 | 341/261 | Healthy volunteers | 8.4 | 4.8 | 15.9 | 0.49 | 0.42 | 0.85 |
8 | Torres | Colombia (W) | 2004 | 44/66 | Clinic based | 7.6 | — | — | 0.51 | — | — |
9 | Wu | Taiwan (E) | 2004 | 204/210 | Healthy volunteers | 12.4 | 1.7 | 14.3 | <0.01 | <0.01 | 0.20 |
10 | Ohayama | Japan (E) | 2004 | 300/472 | Clinic based | — | — | 18.6 | — | — | 0.90 |
11 | Garza-Gonzalez | Mexico (W) | 2005 | 63/215 | Clinic based | 8.6 | — | — | 0.61 | — | — |
12 | Guo | China (E) | 2005 | 264/437 | Healthy volunteers | 5.9 | — | — | <0.01 | — | — |
13 | Lee JY | Korea (E) | 2005 | 122/120 | Healthy volunteers | 7.1 | — | — | 0.40 | — | — |
14 | Li | China (E) | 2005 | 59/264 | Healthy volunteers | 7.2 | — | — | 0.56 | — | — |
15 | Lu | China (E) | 2005 | 250/300 | Population based | 4.7 | 3.8 | — | 0.08 | 0.49 | — |
16 | Perri | Italy (W) | 2005 | 184/362 | Healthy volunteers | 10.9 | — | — | 0.15 | — | — |
17 | Rocha | Brazil (W) | 2005 | 161/535 | Healthy volunteers | 13.9 | — | — | 0.34 | — | — |
18 | Zambon | Italy (W) | 2005 | 129/644 | Clinic based | 12.3 | 5.9 | 19.6 | 0.90 | 0.38 | <0.01 |
19 | Kamangar | Finland (W) | 2006 | 112/208 | Healthy cohort subjects | 13.5 | 1.2 | — | 0.29 | 0.86 | — |
20 | Kim | Korea (E) | 2006 | 237/461 | Healthy volunteers | 6.8 | — | — | 0.91 | — | — |
21 | Morgan | Honduras (W) | 2006 | 168/161 | Population based | 3.7 | — | — | 0.62 | — | — |
22 | Hou | Poland (W) | 2007 | 305/427 | Population based | 16.2 | — | — | 0.19 | — | — |
23 | Sugimoto | Japan (E) | 2007 | 105/172 | Clinic based | 0.9 | — | 15.7 | 0.91 | — | 0.11 |
24 | Garcia-Gonzalez | Spain (W) | 2007 | 404/404 | Healthy volunteers | 11.3 | 10.3 | — | 0.35 | 0.01 | — |
E=East Asian country; HWE=Hardy–Weinberg equilibrium; TNF-A=tumour-necrosis factor-A; W=western country.
Year: Publication year.
Percentage of TNF-A –308A allele frequency among controls.
Percentage of TNF-A –238 A allele frequency among controls.
Percentage of TNF-A –857 T allele frequency among controls.
P-value for HWE for TNF-A –308 polymorphism among controls.
P-value for HWE for TNF-A –238 polymorphism among controls.
P-value for HWE for TNF-A –857 polymorphism among controls.